Jan Henrik ter Meulen
Direktor/Vorstandsmitglied bei Virometix AG
Aktive Positionen von Jan Henrik ter Meulen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Virometix AG
Virometix AG Pharmaceuticals: MajorHealth Technology Virometix AG is a Swiss biotechnology company that focuses on developing vaccines and immunotherapeutic drugs for the prevention and treatment of infections and cancer. Virometix is based in Schlieren, CH. The private company's mission is to address the growing medical need for vaccines to combat infectious and chronic human diseases. The company was founded by John Anthony Robinson, and the CEO is Anna Sumeray. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Jan Henrik ter Meulen
Ehemalige bekannte Positionen von Jan Henrik ter Meulen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IMMUNE DESIGN CORP | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2013 | 02.04.2019 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | 01.01.2008 | - |
Etna Biotech SRL
Etna Biotech SRL Miscellaneous Commercial ServicesCommercial Services Etna Biotech SRL provides bio-pharmaceutical research and develops vaccines. It engages in researching and developing vaccines and immunotherapeutics for infectious diseases and other chronic illnesses. The company was founded in 2001 and is headquartered in Catania, Italy. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2006 | - |
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Corporate Officer/Principal | 01.03.2003 | - |
MERCK & CO., INC. | Corporate Officer/Principal | - | - |
Ausbildung von Jan Henrik ter Meulen
University of Freiburg | Doctorate Degree |
Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Philipps University of Marburg | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Deutschland | 4 |
Italien | 2 |
Operativ
Doctorate Degree | 3 |
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 4 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
Etna Biotech SRL
Etna Biotech SRL Miscellaneous Commercial ServicesCommercial Services Etna Biotech SRL provides bio-pharmaceutical research and develops vaccines. It engages in researching and developing vaccines and immunotherapeutics for infectious diseases and other chronic illnesses. The company was founded in 2001 and is headquartered in Catania, Italy. | Commercial Services |
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Virometix AG
Virometix AG Pharmaceuticals: MajorHealth Technology Virometix AG is a Swiss biotechnology company that focuses on developing vaccines and immunotherapeutic drugs for the prevention and treatment of infections and cancer. Virometix is based in Schlieren, CH. The private company's mission is to address the growing medical need for vaccines to combat infectious and chronic human diseases. The company was founded by John Anthony Robinson, and the CEO is Anna Sumeray. | Health Technology |
- Börse
- Insiders
- Jan Henrik ter Meulen
- Erfahrung